StockData
Inovio Pharmaceuticals, Inc. logo

Inovio Pharmaceuticals, Inc. (INO) stock

INONasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 4/30
$1.63+0.23 (+16.43%)

Close on Nov 17, 2026Market cap $168.54MP/E –Yield –

Inovio Pharmaceuticals enterprise value

Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.

Inovio Pharmaceuticals's enterprise value was $84.75M on Nov 11, 2026, against $59.56M a year earlier. Over the last 5 years it ranged from -$105.57M to $654.85M, with a median of $39.67M.

Enterprise Value at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$84.75M+99.8%
2025Dec 31, 2025$42.41M–
2024Dec 31, 2024-$37.12M–
2023Dec 29, 2023-$29.93M-127.9%
2022Dec 30, 2022$107.31M-83.6%
2021Dec 31, 2021$654.85M-42.8%
2020Dec 31, 2020$1.15B+386.5%
2019Dec 31, 2019$235.49M-19.5%
2018Dec 31, 2018$292.50M+26.5%
2017Dec 29, 2017$231.14M-41.3%
2016Dec 30, 2016$393.76M+25.2%
2015Dec 31, 2015$314.52M-30.8%
2014Dec 31, 2014$454.39M-18.3%
2013Dec 31, 2013$556.39M+965.7%
2012Dec 31, 2012$52.21M+13.6%
2011Jul 29, 2011$45.98M–

More Inovio Pharmaceuticals figures

See a number that looks wrong?